Clinical Trials Browser

Phase 2 × OTHER × Core Binding Factor Acute Myeloid Leukemia × Clear all

NCT05821738 2023-05-09

Avapritinib in CBF-AML With KIT Mutations

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Core Binding Factor Acute Myeloid Leukemia